NCT02555449View on ClinicalTrials.gov

A Study of [¹⁴C]-LY3202626 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Healthy
Interventions
DRUG

[¹⁴C]-LY3202626

Administered as solution by mouth

Trial Locations (1)

53704

Covance Clinical Research Unit Inc., Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02555449 - A Study of [¹⁴C]-LY3202626 in Healthy Male Participants | Biotech Hunter | Biotech Hunter